Cited by — CPX-351 plus gemtuzumab ozogamicin in relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite CPX-351 plus gemtuzumab ozogamicin in relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
No admitted local citation edges point to this work yet.
